C50
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: • Mamma-Carzinoma in female Patients, max. 6 months after medicinical treatment • written and valid decleraton of agreement of the patient • Age > 18 Jahre • Hb > 9 g/dl • EF > 60% • FEV1 > 50%
Exclusion criteria
Exclusion criteria: • Metastasis • Chemotherapie/Operation not longer as 6 months in the past • Heavy internistic, neurologic or orthopedic affection, which not allow any sport activities • Heart insufficiency (NYHA III-IV) • Respiratory Partial- oder Globalinsufficiency • Thrombozytopenia <10.000/µl, e.g. Autoimmunthrombozytopenia • Hereditary or acquired Thrombozytopathy or coagulation disturbance • Symptomatic coronary heart disease • Heavy Hypertonia • COPD • cerebral spasms • Heavy psychologic illness • Physical or psychologic constitution which exclude the patient from the sport intervention or no singed decleration of agreement • missing willingess for saving peronal data • Participation at a sportive study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The measurement of the primary endpoint (quality of life) was evaluated using the EORTC (European Organization for Research and Treatment of Cancer) Quality-of-Life Questionnaire “QLQ-C30” and “BR 23“ at Baseline, after 12 (T1), 24 (T2), 28 (T3), 40 (T4) and 52 Wochen (T5). | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcomes were Stressmenagement (measured with Perceived Stress Questionnaire 20), level of physical activity (measured with Global Physical Activity Questionnaire - WHO), fear and depression (measured with Hospital Anxiety and Depression Scale) and self-efficacy (measured with Allgemeine Selbstwirksamkeitserwartung). All outcomes should be measured at baseline, at the end of week 12 (T1), 24 (T2), 28 (T3), 40 (T4) and 52 (T5). | — |
Countries
Germany
Contacts
Deutsche Sporthochschule Köln